New Drugs

FDA Approves Juvéderm Volbella XC For Undereye Hollows

Written by David Miller

IRVINE, Calif., Feb. 8, 2022 /PRNewswire/ — Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the FDA approval of Juvéderm® Volbella® XC for improvement of infraorbital hollows in adults over the age of 21.2 According to…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]